Go Pro

KORU Medical Systems (KRMD) Competitors

KORU Medical Systems logo
$3.23 +0.03 (+0.94%)
As of 08/28/2026 04:00 PM Eastern

KRMD vs. DCTH, BWAY, TCMD, NPCE, and CLPT

Should you buy KORU Medical Systems stock or one of its competitors? KORU Medical Systems's main competitors and comparable companies include Delcath Systems (DCTH), Brainsway (BWAY), Tactile Systems Technology (TCMD), NeuroPace (NPCE), and ClearPoint Neuro (CLPT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does KORU Medical Systems compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability and institutional ownership.

Delcath Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market.

Delcath Systems presently has a consensus price target of $23.17, suggesting a potential upside of 41.78%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 116.72%. Given KORU Medical Systems' higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.86
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, KORU Medical Systems had 1 more articles in the media than Delcath Systems. MarketBeat recorded 4 mentions for KORU Medical Systems and 3 mentions for Delcath Systems. KORU Medical Systems' average media sentiment score of 1.22 beat Delcath Systems' score of 0.98 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Delcath Systems
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
KORU Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Delcath Systems has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$85.23M6.65$2.70M$0.011,634.00
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Delcath Systems has a net margin of 0.56% compared to KORU Medical Systems' net margin of -4.03%. Delcath Systems' return on equity of 0.46% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems0.56% 0.46% 0.42%
KORU Medical Systems -4.03%-10.63%-6.51%

Summary

Delcath Systems beats KORU Medical Systems on 14 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Brainsway?

KORU Medical Systems (NASDAQ:KRMD) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Brainsway has a net margin of 15.65% compared to KORU Medical Systems' net margin of -4.03%. Brainsway's return on equity of 12.74% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
Brainsway 15.65%12.74%8.17%

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
Brainsway$52.22M11.01$7.57M$0.4432.50

KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, Brainsway has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

KORU Medical Systems presently has a consensus price target of $7.00, indicating a potential upside of 116.72%. Brainsway has a consensus price target of $16.95, indicating a potential upside of 18.53%. Given KORU Medical Systems' higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Brainsway
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, KORU Medical Systems had 2 more articles in the media than Brainsway. MarketBeat recorded 4 mentions for KORU Medical Systems and 2 mentions for Brainsway. KORU Medical Systems' average media sentiment score of 1.22 beat Brainsway's score of 0.85 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Brainsway
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Brainsway beats KORU Medical Systems on 12 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

Tactile Systems Technology (NASDAQ:TCMD) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

In the previous week, Tactile Systems Technology had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 6 mentions for Tactile Systems Technology and 4 mentions for KORU Medical Systems. Tactile Systems Technology's average media sentiment score of 1.70 beat KORU Medical Systems' score of 1.22 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
KORU Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tactile Systems Technology$329.52M1.59$19.09M$1.0821.44
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A

Tactile Systems Technology has a net margin of 7.10% compared to KORU Medical Systems' net margin of -4.03%. Tactile Systems Technology's return on equity of 11.49% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology7.10% 11.49% 9.17%
KORU Medical Systems -4.03%-10.63%-6.51%

Tactile Systems Technology presently has a consensus target price of $38.40, suggesting a potential upside of 65.80%. KORU Medical Systems has a consensus target price of $7.00, suggesting a potential upside of 116.72%. Given KORU Medical Systems' higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Tactile Systems Technology has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Tactile Systems Technology beats KORU Medical Systems on 12 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to NeuroPace?

KORU Medical Systems (NASDAQ:KRMD) and NeuroPace (NASDAQ:NPCE) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

KORU Medical Systems currently has a consensus price target of $7.00, suggesting a potential upside of 116.72%. NeuroPace has a consensus price target of $19.29, suggesting a potential upside of 33.84%. Given KORU Medical Systems' higher probable upside, equities analysts clearly believe KORU Medical Systems is more favorable than NeuroPace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
NeuroPace
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.78

KORU Medical Systems has higher earnings, but lower revenue than NeuroPace. KORU Medical Systems is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
NeuroPace$99.99M4.95-$21.47M-$0.57N/A

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 78.8% of NeuroPace shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 19.2% of NeuroPace shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

KORU Medical Systems has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, NeuroPace has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market.

KORU Medical Systems has a net margin of -4.03% compared to NeuroPace's net margin of -19.34%. KORU Medical Systems' return on equity of -10.63% beat NeuroPace's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
NeuroPace -19.34%-105.64%-16.51%

In the previous week, KORU Medical Systems had 2 more articles in the media than NeuroPace. MarketBeat recorded 4 mentions for KORU Medical Systems and 2 mentions for NeuroPace. KORU Medical Systems' average media sentiment score of 1.22 beat NeuroPace's score of 1.17 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeuroPace
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

NeuroPace beats KORU Medical Systems on 9 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to ClearPoint Neuro?

KORU Medical Systems (NASDAQ:KRMD) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 116.72%. ClearPoint Neuro has a consensus target price of $25.67, indicating a potential upside of 65.06%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe KORU Medical Systems is more favorable than ClearPoint Neuro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
ClearPoint Neuro
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

KORU Medical Systems has higher revenue and earnings than ClearPoint Neuro. KORU Medical Systems is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
ClearPoint Neuro$36.97M12.83-$25.54M-$1.18N/A

In the previous week, KORU Medical Systems had 1 more articles in the media than ClearPoint Neuro. MarketBeat recorded 4 mentions for KORU Medical Systems and 3 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.34 beat KORU Medical Systems' score of 1.22 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ClearPoint Neuro
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

KORU Medical Systems has a net margin of -4.03% compared to ClearPoint Neuro's net margin of -81.76%. KORU Medical Systems' return on equity of -10.63% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
ClearPoint Neuro -81.76%-188.09%-40.88%

KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

KORU Medical Systems beats ClearPoint Neuro on 12 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRMD vs. The Competition

MetricKORU Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$148.36M$5.88B$7.21B$12.90B
Dividend YieldN/A1.75%2.54%11.28%
P/E Ratio-80.7521.48212.6221.91
Price / Sales3.6168.66625.8692.63
Price / CashN/A33.6928.7436.03
Price / Book8.736.1811.086.36
Net Income-$2.64M$149.94M$3.48B$349.79M
7 Day Performance0.62%-0.24%0.13%-0.80%
1 Month Performance-21.41%6.18%7.08%4.13%
1 Year Performance-23.46%6.30%24.67%15.17%

KORU Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRMD
KORU Medical Systems
4.2328 of 5 stars
$3.23
+0.9%
$7.00
+116.7%
-23.5%$148.36M$41.13MN/A80
DCTH
Delcath Systems
3.7692 of 5 stars
$16.92
+1.0%
$23.17
+36.9%
+48.3%$581.21M$85.23M1,693.6960
BWAY
Brainsway
4.1779 of 5 stars
$14.43
+1.7%
$16.95
+17.5%
+83.8%$569.46M$52.22M32.80120
TCMD
Tactile Systems Technology
4.282 of 5 stars
$23.58
+0.9%
$38.40
+62.8%
+74.0%$529.16M$329.52M21.831,086
NPCE
NeuroPace
3.496 of 5 stars
$14.16
+1.2%
$19.29
+36.2%
+57.5%$480.20M$99.99MN/A170

Related Companies and Tools


This page (NASDAQ:KRMD) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners